No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2528 |
4. Check minimum number of eventsNone |
2528 |
5. Include endpoints |
2528 |
6. Filter based on genotype QC (FinnGen only) |
2528 |
Control definitions (FinnGen only)
- Control exclude
- F5_PSYCHDEV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- F80-F89
- Name in latin
- Perturbationes specificae progressus dictionis et linguae
Similar endpoints
↥List of similar endpoints to
Specific development disorders of speech and language
based on the number of shared cases.
Similar with more cases:
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 65508 | 19893 | 45590 |
| Only index persons | 49393 | 15358 | 34035 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.06 | 0.57 | 1.27 |
| Only index persons | 1.07 | 0.56 | 1.30 |
| Median age at first event (years) | |||
| Whole population | 5.39 | 5.72 | 5.22 |
| Only index persons | 5.75 | 6.18 | 5.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2528 | 1177 | 1351 |
| Unadjusted period prevalence (%) | 0.51 | 0.40 | 0.60 |
| Median age at first event (years) | 7.36 | 8.89 | 6.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2144
- Matched controls
- 21042
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F80.1
ICD-10 Finland
Expressive language disorder
4609.8
323.0
1075
*
F80.2
ICD-10 Finland
Receptive language disorder
1413.8
323.0
455
*
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
882.9
320.3
309
*
F80.0
ICD-10 Finland
Specific speech articulation disorder
106.5
267.0
291
31
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
223.5
212
*
F83
ICD-10 Finland
Mixed specific developmental disorders
735.0
208.8
204
*
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
327.5
180.8
182
6
F82
ICD-10 Finland
Specific developmental disorder of motor function
289.1
160.8
163
6
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
143.4
137
*
R62.0
ICD-10 Finland
Delayed milestone
18.9
115.1
181
102
F81.0
ICD-10 Finland
Specific reading disorder
63.7
95.0
111
18
XA800
NOMESCO Finland
Neuropsychological investigation
7.5
89.5
223
319
Z2445
NOMESCO Finland
Psychologist
4.9
83.1
298
673
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
287.2
82.6
84
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
13.6
74.1
132
101
AA1AD
NOMESCO Finland
CT of head and brain
3.1
72.7
474
1770
Z3226
NOMESCO Finland
Physiotherapist
2.9
69.5
509
2046
Z2446
NOMESCO Finland
Social worker
3.6
66.5
330
999
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
66.2
255
614
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
43.4
65.0
81
19
Z50.5
ICD-10 Finland
Speech therapy
8.8
64.8
144
170
R4130
NOMESCO Finland
Speech therapy
10.8
64.5
128
123
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.1
63.6
401
1451
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
5.6
55.0
168
312
Z2221
NOMESCO Finland
Medical doctor
2.3
51.3
612
3141
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.3
49.9
200
496
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
38.5
47.9
61
16
R1260
NOMESCO Finland
Evaluation of communicative skills
11.8
47.8
90
78
F84.5
ICD-10 Finland
Asperger syndrome
30.3
46.8
63
21
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
125.5
46.6
50
*
N03AG01
ATC
valproic acid; systemic, rectal
3.9
46.1
201
538
Z3231
NOMESCO Finland
Registered nurse
2.1
44.5
663
3715
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
43.8
419
1908
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
43.2
249
831
R47.0
ICD-10 Finland
Dysphasia and aphasia
24.2
42.0
60
25
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.1
41.7
172
437
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
54.6
41.2
49
9
N05AX08
ATC
risperidone; systemic
3.2
40.8
229
749
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
7.9
40.6
95
122
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.9
39.5
268
994
ZY010
NOMESCO Finland
Hospital outpatient
3.1
39.3
236
807
R4110
NOMESCO Finland
Physiotherapy
2.1
39.2
518
2734
R4120
NOMESCO Finland
Occupational therapy
3.9
38.5
170
459
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.1
37.9
232
805
N05AH03
ATC
olanzapine; systemic
3.2
37.9
215
708
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
15.1
37.6
63
42
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.3
37.1
202
645
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
36.9
123
252
F80
ICD-10 Finland
Specific developmental disorders of speech and language
356.5
35.8
36
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
35.5
210
709
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
35.1
225
805
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
34.5
240
901
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
34.2
33
*
N05AH04
ATC
quetiapine; oral
2.2
33.9
423
2157
N03AF02
ATC
oxcarbazepine; oral
4.5
33.3
122
276
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
33.0
194
653
30600
ICD-8 Finland
Special symptoms not elsewhere classified, Stammering and stuttering
+∞
32.1
31
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.3
32.1
123
291
F84.0
ICD-10 Finland
Childhood autism
+∞
31.1
30
*
N05AX12
ATC
aripiprazole; systemic
3.2
31.1
174
564
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
8.1
30.9
71
89
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
42.1
30.6
38
9
F81.1
ICD-10 Finland
Specific spelling disorder
84.8
30.6
34
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.5
30.3
152
455
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
30.3
335
1612
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
30.1
29
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
29.9
230
916
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
29.6
274
1206
N03AX14
ATC
levetiracetam; systemic
4.8
28.2
96
202
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.0
28.1
170
581
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
27.8
672
4330
RL140
NOMESCO Finland
NA
16.1
27.8
45
28
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
27.5
180
648
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
27.3
608
3809
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
27.3
154
503
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.8
26.9
120
327
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
269.3
26.6
27
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
26.5
217
894
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.9
26.3
166
585
R47.1
ICD-10 Finland
Dysarthria and anarthria
14.7
26.2
44
30
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.9
26.0
164
577
B01AC04
ATC
clopidogrel; oral
2.8
25.8
176
652
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
25.2
196
782
A28
ICPC
Limited function/disability NOS
2.5
25.2
218
926
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
24.6
403
2261
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
24.6
254
1176
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
24.2
646
4252
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.9
24.0
102
267
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.1
23.6
95
237
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.8
23.4
102
273
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
23.2
197
827
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
23.1
296
1507
RT150
NOMESCO Finland
NA
10.0
23.0
46
46
RL130
NOMESCO Finland
NA
13.3
23.0
40
30
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
22.9
355
1946
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
22.8
375
2101
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.1
22.7
130
429
F88
ICD-10 Finland
Other disorders of psychological development
82.8
22.5
25
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.1
22.1
89
222
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.5
22.1
79
176
N06BA04
ATC
methylphenidate; oral
3.0
21.9
135
466
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.7
21.5
96
262
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
26.2
21.1
29
11
ZXE00
NOMESCO Finland
One hour or less
1.6
21.0
731
5126
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
21.0
139
505
WX892
NOMESCO Finland
Monitored bed care
2.6
20.9
160
632
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
20.8
157
616
P24
ICPC
Specific learning problem
4.9
20.8
69
142
N05BA01
ATC
diazepam; systemic, rectal
2.2
20.5
224
1062
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.2
20.4
78
186
N03AX09
ATC
lamotrigine; oral
2.8
20.4
136
497
N19
ICPC
Speech disorder
4.2
20.2
78
188
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
7.1
20.0
49
69
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.1
19.1
60
117
R41.0
ICD-10 Finland
Disorientation, unspecified
4.9
19.0
62
126
R42
ICD-10 Finland
Dizziness and giddiness
1.9
18.9
311
1734
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.7
18.8
135
517
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
18.7
332
1903
R55
ICD-10 Finland
Syncope and collapse
2.3
18.5
180
808
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.0
18.3
45
64
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
14.9
18.2
30
20
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
8.5
17.9
39
46
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
17.9
225
1130
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
17.9
292
1623
F80.3
ICD-10 Finland
Acquired aphasia with epilepsy [Landau-Kleffner]
+∞
17.6
17
*
183
Kela drug reimbursment
Lamotrigin and topiramate
5.9
17.6
49
83
N05CD08
ATC
midazolam; nasal, systemic
4.5
17.5
63
142
N05AH02
ATC
clozapine; systemic
3.8
17.5
74
194
P99
ICPC
Psychological disorders other
3.3
17.4
90
278
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
17.3
500
3308
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.0
17.3
104
355
L17
ICPC
Foot/toe symptom/complaint
1.6
17.3
481
3154
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
17.2
324
1893
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.5
17.1
80
229
WX882
NOMESCO Finland
High dependency care
2.8
17.0
114
419
N06AB04
ATC
citalopram; systemic
1.8
17.0
293
1659
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.6
16.9
59
129
P22
ICPC
Child behaviour symptom/complaint
3.9
16.8
69
177
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.6
16.5
122
476
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
27.2
16.3
22
8
L28
ICPC
Limited function/disability (L)
2.0
16.3
210
1067
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.9
16.3
53
108
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.0
16.1
65
164
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
16.0
341
2065
N05BA09
ATC
clobazam; oral
6.1
16.0
43
70
C10AA05
ATC
atorvastatin; oral
1.7
15.9
337
2036
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
24.2
15.8
22
9
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.5
15.7
46
83
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.8
15.7
102
368
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
15.7
87
283
F89
ICD-10 Finland
Unspecified disorder of psychological development
59.3
15.6
18
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.4
15.6
57
131
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
15.5
15
*
R5599
NOMESCO Finland
Other rehabilitation service
3.6
15.5
71
200
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
15.5
301
1773
R1250
NOMESCO Finland
Evaluation of functional capability
4.4
15.4
55
124
N05AD01
ATC
haloperidol; systemic
4.0
15.3
62
157
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.9
15.3
94
327
IGV01
NOMESCO Finland
Psychiatric network contact
4.4
15.3
55
125
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.2
15.2
58
139
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
12.2
15.2
27
22
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.1
15.0
47
92
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
15.0
127
532
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.4
15.0
39
61
K03.66
ICD-10 Finland
Tooth plaque
2.0
14.9
201
1036
R51.80
ICD-10 Finland
Headache
1.7
14.7
326
1992
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
56.0
14.7
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
14.6
148
678
XX4AW
NOMESCO Finland
NA
6.5
14.4
37
57
N06AX11
ATC
mirtazapine; oral
1.6
14.3
469
3184
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
35.6
14.3
18
5
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.0
14.2
83
280
N05AA02
ATC
levomepromazine; systemic
3.3
14.1
72
221
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.2
14.1
43
82
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.1
14.1
76
243
ZXA10
NOMESCO Finland
Bilateral
1.7
14.1
306
1860
RT420
NOMESCO Finland
NA
14.2
13.9
23
16
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
5.9
13.8
38
64
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.0
13.7
54
134
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
13.7
664
4916
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.6
13.6
46
99
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
9.0
13.5
28
31
WX110
NOMESCO Finland
Local anesthesy
1.4
13.4
1423
12201
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
138.2
13.4
14
*
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
6.1
13.1
35
57
C08CA01
ATC
amlodipine; oral
1.7
13.1
317
1984
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
13.1
154
753
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
13.1
315
1969
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
6.1
12.8
34
55
RT160
NOMESCO Finland
NA
7.9
12.6
28
35
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.5
12.5
99
400
A06AD11
ATC
lactulose; oral
1.9
12.5
186
997
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
12.4
12
*
DFF20
NOMESCO Finland
Audiometry for children
6.4
12.4
32
50
RS220
NOMESCO Finland
NA
3.8
12.4
51
133
H01AC01
ATC
somatropin; parenteral
4.2
12.3
46
110
M79.6
ICD-10 Finland
Pain in limb
1.5
12.2
528
3800
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
12.2
156
790
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
12.1
114
503
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
12.1
129
605
P07.2
ICD-10 Finland
Extreme immaturity
37.1
12.1
15
*
R13
ICD-10 Finland
Dysphagia
2.6
12.0
87
336
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
12.0
71
243
WX002
NOMESCO Finland
Sedation and analgesia
1.7
12.0
258
1562
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.6
12.0
53
147
R5120
NOMESCO Finland
Preparation of an aid
4.3
11.9
43
99
S18
ICPC
Laceration/cut
1.4
11.9
644
4840
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
11.9
307
1954
RS140
NOMESCO Finland
NA
6.9
11.9
29
42
P29
ICPC
Psychological sympt/compl other
1.9
11.8
177
953
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
6.2
11.8
31
50
PA7BD
NOMESCO Finland
CT angiography of neck and brain
5.9
11.7
32
54
P85
ICPC
Mental retardation
7.4
11.7
27
36
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.0
11.7
46
115
H81
ICPC
Excessive ear wax
1.8
11.7
210
1202
IEP99
NOMESCO Finland
Other psychiatric family intervention
4.6
11.6
39
84
N05AN01
ATC
lithium; oral
3.4
11.6
56
167
RT490
NOMESCO Finland
NA
16.2
11.5
18
11
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
11.5
143
717
N05BA04
ATC
oxazepam; oral
1.6
11.5
355
2362
Z71.8
ICD-10 Finland
Other specified counselling
1.5
11.4
492
3531
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.6
11.4
50
138
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
11.4
11
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.8
11.3
47
124
H50.31
ICD-10 Finland
Intermittent exotropia
3.6
11.3
50
139
N17
ICPC
Vertigo/dizziness
1.8
11.3
184
1021
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
11.3
155
807
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
11.2
539
3955
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.1
1219
10329
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.3
11.1
56
172
RS222
NOMESCO Finland
NA
4.2
11.1
41
97
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.8
11.1
184
1024
ZXD05
NOMESCO Finland
Urgent procedure
1.5
11.1
500
3616
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
24.7
11.0
15
6
C03CA01
ATC
furosemide; systemic
1.7
10.9
262
1632
N03AX11
ATC
topiramate; oral
3.2
10.9
55
170
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
5.7
10.8
30
52
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.9
10.8
67
235
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.6
10.8
48
134
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.6
471
3392
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
17.6
10.6
16
9
G40.10
ICD-10 Finland
Simple partial seizures
4.8
10.6
34
70
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
10.6
88
368
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
21.2
10.6
15
7
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.2
10.6
53
163
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
10.6
96
420
K90
ICPC
Stroke/cerebrovascular accident
4.2
10.5
39
93
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
4.1
10.5
40
98
N05AB03
ATC
perphenazine; systemic, rectal
3.0
10.5
60
201
F05.9
ICD-10 Finland
Delirium, unspecified
4.5
10.5
36
80
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.9
10.4
164
900
H52.2
ICD-10 Finland
Astigmatism
3.0
10.4
57
187
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.2
10.4
31
59
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
10.4
107
495
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.0
10.4
59
196
3140B
ICD-9 Finland
Hyperkinetic syndrome of childhood, Attention deficit disorder
108.5
10.3
11
*
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.9
10.3
61
210
ZXA05
NOMESCO Finland
Left side
1.6
10.3
308
2032
SPAT1216
SPAT
Assessment of functional ability
1.7
10.3
198
1157
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
4.5
10.3
35
77
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
10.1
142
746
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
10.1
281
1821
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
10.1
100
455
TAB00
NOMESCO Finland
Lumbar puncture
2.3
10.1
88
379
N03AE01
ATC
clonazepam; systemic
2.4
10.1
84
352
N18
ICPC
Paralysis/weakness
4.8
10.0
32
66
SPAT1307
SPAT
Psychosocial counselling and guidance
1.6
10.0
248
1560
A02BC02
ATC
pantoprazole; systemic
1.4
9.9
816
6558
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
9.9
95
428
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
39.4
9.9
12
*
F70
ICD-10 Finland
Mild mental retardation
39.4
9.9
12
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.5
9.9
74
294
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
9.8
251
1589
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.5
9.8
73
288
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.6
9.8
43
120
XA820
NOMESCO Finland
NA
8.0
9.7
21
26
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
9.7
659
5131
F21
ICD-10 Finland
Schizotypal disorder
6.9
9.6
23
33
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
9.6
111
540
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
9.6
357
2473
N30.0
ICD-10 Finland
Acute cystitis
1.6
9.6
227
1409
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.9
9.6
57
198
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
9.6
76
312
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
54.2
9.6
11
*
IEY01
NOMESCO Finland
Psychoeducation, individual
4.1
9.5
36
88
A04
ICPC
Weakness/tiredness general
1.6
9.5
288
1902
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
9.5
370
2589
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.4
9.5
45
133
R41.3
ICD-10 Finland
Other amnesia
3.8
9.5
39
103
P72
ICPC
Schizophrenia
3.3
9.5
46
139
N06AX16
ATC
venlafaxine; oral
1.6
9.5
226
1407
RD210
NOMESCO Finland
NA
2.4
9.4
75
309
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
9.4
171
982
N28
ICPC
Limited function/disability (N)
5.0
9.4
29
58
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
98.6
9.3
10
*
SPAT1234
SPAT
Support of social functional capacity
2.4
9.3
77
322
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
9.3
126
654
F94.0
ICD-10 Finland
Elective mutism
17.3
9.3
14
8
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
6.1
9.2
24
39
Z31.5
ICD-10 Finland
Genetic counselling
2.1
9.2
108
528
L12
ICPC
Hand/finger symptom/complaint
1.5
9.2
306
2069
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
9.2
50
164
D12
ICPC
Constipation
2.7
9.2
62
232
K89
ICPC
Transient cerebral ischaemia
8.5
9.2
19
22
ZXA00
NOMESCO Finland
Right side
1.5
9.1
326
2239
N06AB06
ATC
sertraline; oral
1.7
9.1
199
1208
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.9
9.1
36
92
C07AB02
ATC
metoprolol; systemic
1.7
9.1
192
1153
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
2.4
9.1
76
321
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.5
9.1
31
69
N03AX18
ATC
lacosamide; systemic
5.0
9.1
28
56
XF404
NOMESCO Finland
Ambulatory ECG
1.9
9.1
128
675
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
13.5
9.1
15
11
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.8
9.0
57
205
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
9.0
1016
8525
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.6
9.0
39
108
P20
ICPC
Memory disturbance
2.0
8.9
113
573
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
8.9
92
428
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.7
8.9
60
224
IGP01
NOMESCO Finland
Psychiatric family contact
2.8
8.9
56
201
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
8.9
120
622
R11
ICD-10 Finland
Nausea and vomiting
1.7
8.8
173
1016
N06AB10
ATC
escitalopram; oral
1.5
8.8
376
2677
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.8
8.8
141
777
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
4.4
8.8
30
67
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
8.8
174
1025
N05AF03
ATC
chlorprothixene; systemic
3.0
8.7
50
168
RS211
NOMESCO Finland
NA
4.3
8.7
31
72
N06AB03
ATC
fluoxetine; oral
1.7
8.7
187
1131
R25.1
ICD-10 Finland
Tremor, unspecified
3.1
8.7
45
143
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
8.7
163
946
SPAT1229
SPAT
Assessment of need for aid
2.2
8.7
89
415
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.9
8.6
34
87
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
8.6
466
3475
K59.0
ICD-10 Finland
Constipation
2.1
8.5
95
459
RK320
NOMESCO Finland
NA
6.5
8.5
21
32
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
8.5
905
7507
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
8.5
306
2105
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
4.4
8.5
29
65
B01AA03
ATC
warfarin; systemic
1.7
8.5
178
1068
R27.0
ICD-10 Finland
Ataxia, unspecified
11.4
8.5
15
13
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
8.5
113
584
G12.2
ICD-10 Finland
Motor neuron disease
16.0
8.5
13
8
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
8.4
380
2734
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.8
8.4
53
189
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.4
8.4
68
282
H52.0
ICD-10 Finland
Hypermetropia
2.6
8.4
61
238
ZXD20
NOMESCO Finland
Day surgery
1.7
8.4
193
1189
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
88.7
8.4
9
*
EMB30
NOMESCO Finland
Adenotomy
1.6
8.3
210
1326
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
8.3
106
539
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
5.3
8.3
24
45
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
+∞
8.3
8
*
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
+∞
8.3
8
*
R53
ICD-10 Finland
Malaise and fatigue
1.5
8.3
325
2278
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.8
8.3
52
186
WX402
NOMESCO Finland
General anaesthesia
1.5
8.2
275
1858
N04AA02
ATC
biperiden; systemic
3.6
8.2
35
96
ZY000
NOMESCO Finland
Hospital inpatient
2.8
8.2
52
187
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
8.2
233
1516
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.4
8.2
69
291
RS314
NOMESCO Finland
NA
10.6
8.2
15
14
EB1WA
NOMESCO Finland
NA
5.2
8.2
24
46
R49.08
ICD-10 Finland
Other specified dysphonia
4.1
8.1
30
73
UDC00
NOMESCO Finland
Ear microscopy
1.8
8.1
147
844
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
8.0
250
1664
H01
ICPC
Ear pain/earache
1.5
8.0
281
1920
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.4
8.0
37
109
FM2CE
NOMESCO Finland
NA
2.4
8.0
65
271
F98.5
ICD-10 Finland
Stuttering [stammering]
11.5
8.0
14
12
RT250
NOMESCO Finland
NA
8.0
8.0
17
21
P28
ICPC
Limited function/disability (P)
4.6
8.0
26
56
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
7.9
358
2573
G81.1
ICD-10 Finland
Spastic hemiplegia
21.7
7.9
11
5
WX704
NOMESCO Finland
Intubation
1.9
7.9
105
543
K07.24
ICD-10 Finland
Open bite
2.7
7.9
52
194
SPAT1389
SPAT
Visit based on need for special support
1.7
7.9
151
884
G40.89
ICD-10 Finland
Other epilepsy
6.2
7.9
20
32
R4140
NOMESCO Finland
Psychotherapy
3.8
7.9
31
80
J01DB01
ATC
cefalexin; oral
1.3
7.9
1506
13498
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.6
7.9
33
90
N05AF05
ATC
zuclopenthixol; systemic
5.2
7.9
23
44
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
5.8
7.9
21
36
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.7
7.8
52
195
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.8
860
7140
XF402
NOMESCO Finland
ECG with work load test
1.9
7.8
114
611
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.8
7.7
24
49
WX110
SPAT
NA
2.0
7.7
95
477
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.0
7.7
29
72
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
7.7
117
637
A03
ICPC
Fever
1.4
7.6
451
3408
H03AA01
ATC
levothyroxine sodium; systemic
1.5
7.6
262
1784
N01
ICPC
Headache
1.4
7.6
369
2693
N88
ICPC
Epilepsy
4.9
7.6
23
46
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.6
7.6
32
88
K08.3
ICD-10 Finland
Retained dental root
2.1
7.6
83
399
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
4.2
7.5
27
64
XA400
NOMESCO Finland
EEG
5.5
7.5
21
38
Z00.8
ICD-10 Finland
Other general examinations
1.7
7.5
154
921
RS122
NOMESCO Finland
NA
7.9
7.5
16
20
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
11.7
7.5
13
11
RT190
NOMESCO Finland
NA
11.7
7.5
13
11
602
Kela drug reimbursment
Children's severe malnutrition
3.0
7.4
40
132
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
7.4
1423
12689
4122
FHL
Tympanostomy (tympanic tube)
2.1
7.4
84
408
R06.0
ICD-10 Finland
Dyspnoea
1.5
7.4
305
2153
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.4
1045
8950
A99
ICPC
Disease/condition unspecnature/site
1.8
7.4
124
697
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
7.4
91
459
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.8
7.4
44
155
F93.89
ICD-10 Finland
Other childhood emotional disorders
2.4
7.4
58
238
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
7.4
139
808
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
4.6
7.4
24
52
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
7.3
59
247
P15
ICPC
Chronic alcohol abuse
2.7
7.3
47
172
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
7.3
119
661
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
7.5
7.3
16
21
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.5
7.3
16
21
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.7
7.3
155
937
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
5.9
7.3
19
32
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
4.2
7.3
26
62
N05AA01
ATC
chlorpromazine; systemic, rectal
5.2
7.3
21
40
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
7.2
80
384
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
8.2
7.2
15
18
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.9
7.2
28
72
SBB10
NOMESCO Finland
Teeth copy
1.5
7.2
264
1821
D10
ICPC
Vomiting
1.6
7.1
193
1244
IEP03
NOMESCO Finland
Focused parental counselling
3.5
7.1
31
88
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.1
1035
8885
C09CA01
ATC
losartan; oral
1.6
7.1
194
1253
RT130
NOMESCO Finland
NA
7.2
7.1
16
22
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.2
7.1
65
290
U04
ICPC
Incontinence urine
2.5
7.1
51
202
K92.0
ICD-10 Finland
Haematemesis
3.1
7.1
36
115
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.7
7.1
135
792
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.0
899
7581
R33
ICD-10 Finland
Retention of urine
2.1
7.0
72
336
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
7.0
43
155
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.6
7.0
49
189
3459X
ICD-9 Finland
Epilepsy, unspecified
11.8
7.0
12
10
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.0
713
5836
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.4
7.0
58
244
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.5
6.9
19
34
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
9.9
6.9
13
13
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
9.9
6.9
13
13
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.0
6.9
26
65
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
6.9
64
287
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
6.9
6.9
16
23
B01AF02
ATC
apixaban; oral
2.0
6.9
82
408
WZB00
SPAT
NA
0.6
6.9
98
1581
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
1.7
6.9
151
921
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.4
6.9
56
237
W19
ICD-10 Finland
Unspecified fall
1.6
6.8
173
1095
S06.0
ICD-10 Finland
Concussion
1.5
6.8
222
1492
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.8
375
2794
RS230
NOMESCO Finland
NA
6.2
6.8
17
27
T82
ICPC
Obesity
2.3
6.8
60
261
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
5.1
6.8
20
39
AA5PD
NOMESCO Finland
CT examination of brain pefusion
5.7
6.8
18
31
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.8
301
2156
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
6.8
77
375
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.2
6.8
66
303
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
6.8
266
1861
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.3
6.8
32
97
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
4.2
6.8
24
57
SPAT1301
SPAT
No procedures
1.3
6.8
571
4547
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
6.8
267
1870
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.4
6.7
30
87
Q98.5
ICD-10 Finland
Karyotype 47,XYY
39.3
6.7
8
*
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
4.9
6.7
20
40
RS214
NOMESCO Finland
NA
4.9
6.7
20
40
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.9
6.7
20
40
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
6.7
861
7257
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
4.1
6.7
24
58
RT120
NOMESCO Finland
NA
6.0
6.7
17
28
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.0
6.7
17
28
S21
ICPC
Skin texture symptom/complaint
1.5
6.7
201
1328
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.7
195
1278
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
6.6
106
586
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.6
1058
9153
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.6
6.6
152
939
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.2
6.6
32
99
KMAK
NOMESCO Finland
NA
1.3
6.6
856
7218
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.1
6.6
33
105
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.8
6.5
20
41
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
4.8
6.5
20
41
F60.8
ICD-10 Finland
Other specific personality disorders
4.8
6.5
20
41
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.9
6.5
36
122
SPAT1254
SPAT
Administration of medicine
1.4
6.5
330
2420
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
6.3
6.5
16
25
WX730
NOMESCO Finland
Conventional respirator
3.5
6.5
28
79
H50.1
ICD-10 Finland
Divergent concomitant strabismus
3.6
6.5
27
74
DFE00
NOMESCO Finland
Insertion of cochlear implant
7.7
6.5
14
18
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.5
183
1188
R05
ICD-10 Finland
Cough
1.4
6.5
305
2208
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.8
6.5
17
29
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
5.8
6.5
17
29
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.0
6.5
77
382
RS120
NOMESCO Finland
NA
5.4
6.5
18
33
ZXY03
NOMESCO Finland
Occupational therapist
5.4
6.5
18
33
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.3
6.5
55
235
D21
ICPC
Swallowing problem
4.1
6.5
23
55
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.3
6.5
30
90
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
6.5
110
621
C07AB07
ATC
bisoprolol; oral
1.4
6.5
419
3203
P01
ICPC
Feeling anxious/nervous/tense
1.4
6.4
335
2472
WYA30
SPAT
NA
4.7
6.4
20
42
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
6.4
328
2413
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.9
6.4
83
429
Q38.1
ICD-10 Finland
Ankyloglossia
2.9
6.4
37
128
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.6
6.4
42
158
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.6
6.4
43
165
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
6.4
87
459
A11CC03
ATC
alfacalcidol; systemic
2.9
6.3
35
119
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.0
6.3
74
367
WX872
NOMESCO Finland
Intensive care
2.2
6.3
59
264
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
6.3
57
254
WYA20
NOMESCO Finland
Home visit
3.5
6.2
27
77
H50.2
ICD-10 Finland
Vertical strabismus
4.8
6.2
19
39
Z01.2
ICD-10 Finland
Dental examination
1.3
6.2
858
7275
RS141
NOMESCO Finland
NA
10.8
6.2
11
10
30610
ICD-8 Finland
Special symptoms not elsewhere classified, Specific learning disturbance
+∞
6.2
6
*
F81.2
ICD-10 Finland
Specific disorder of arithmetical skills
+∞
6.2
6
*
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
9.1
6.2
12
13
H29
ICPC
Ear symptom/complaint other
1.6
6.2
151
948
N05AE03
ATC
sertindole; oral
5.9
6.2
16
27
XX4BW
NOMESCO Finland
NA
5.9
6.2
16
27
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.2
193
1286
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.9
6.2
83
432
207
Kela drug reimbursment
Chronic arrhythmias
1.7
6.2
115
671
Z25
ICPC
Assault/harmful event problem
3.1
6.2
31
99
F92.0
ICD-10 Finland
Depressive conduct disorder
3.3
6.2
28
83
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
26.3
6.2
8
*
Q93.8
ICD-10 Finland
Other deletions from the autosomes
26.3
6.2
8
*
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
6.2
95
523
A05
ICPC
Feeling ill
1.5
6.1
240
1675
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
6.1
139
854
G04BD12
ATC
mirabegron; oral
1.9
6.1
87
466
Z72.8
ICD-10 Finland
Other problems related to lifestyle
4.2
6.1
21
49
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
6.1
63
297
Z07
ICPC
Education problem
2.5
6.1
45
182
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.0
6.1
32
106
N05CF01
ATC
zopiclone; oral
1.4
6.1
317
2340
W10
ICD-10 Finland
Fall on and from stairs and steps
2.0
6.1
70
347
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.5
6.0
26
74
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
5.6
6.0
16
28
RS312
NOMESCO Finland
NA
7.5
6.0
13
17
P74
ICPC
Anxiety disorder/anxiety state
1.7
6.0
108
622
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
12.3
6.0
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
589
2402
2.78
91.81
3.6
3.7
s
29.8
30.1
0.55
577
2342
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
774
3797
2.39
80.65
3.1
2.2
u/l
212.6
285.1
1.16
758
3586
(3009466) Valproate [Moles/volume] in Serum or Plasma
137
309
4.46
53.17
5.8
5.3
umol/l
392.7
386.8
0.16
127
282
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1086
6979
1.88
49.55
10.8
7.7
mmol/l
1.2
1.2
0.72
1027
6404
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1152
7554
1.87
49.22
10.9
7.7
mmol/l
1.2
1.2
0.82
1050
6539
(3021447) Carbon dioxide [Partial pressure] in Venous blood
438
2079
2.25
46.22
6.8
7.0
kpa
5.8
5.8
1.03
421
2013
(3002032) Base excess in Venous blood by calculation
433
2070
2.23
44.80
6.9
7.1
mmol/l
1.1
1.6
1.59
348
1644
(3024354) Oxygen [Partial pressure] in Venous blood
397
1865
2.25
42.71
6.9
6.9
kpa
4.9
4.9
0.05
382
1808
(3013826) Glucose [Moles/volume] in Serum or Plasma
1330
9412
1.77
41.56
7.0
5.2
mmol/l
6.4
6.4
0.15
1261
8593
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
480
2500
2.05
39.34
5.1
3.6
ng/l
329.4
560.3
1.65
349
1638
(3024561) Albumin [Mass/volume] in Serum or Plasma
942
6131
1.77
38.52
6.7
5.7
g/l
36.7
37.0
1.09
888
5692
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
821
5162
1.79
37.59
2.0
1.8
pmol/l
94.4
96.6
0.70
435
2733
(3003458) Phosphate [Moles/volume] in Serum or Plasma
446
2350
2.01
35.03
10.3
8.2
mmol/l
1.2
1.2
0.08
418
2194
(3000991) Gas panel - Venous blood
378
1894
2.08
34.01
10.6
9.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
682
4182
1.78
33.24
6.4
5.1
%
87.6
89.5
1.25
673
4091
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
846
5537
1.71
32.62
4.5
3.5
u/l
32.2
32.2
0.00
818
5274
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
498
2822
1.87
31.17
3.8
2.8
e6/l
0.9
1.0
0.14
287
1520
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
485
2735
1.88
30.78
3.8
3.0
e6/l
3.7
2.5
1.50
270
1442
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1525
11731
1.64
30.51
8.0
6.6
u/l
93.5
84.8
4.89
1433
11013
(3015377) Calcium [Moles/volume] in Serum or Plasma
732
4693
1.71
29.93
3.6
3.0
mmol/l
2.4
2.4
0.92
652
4176
(3032080) INR in Blood by Coagulation assay
780
5088
1.69
29.90
10.8
6.9
inr
1.2
1.2
0.36
215
1604
(3019550) Sodium [Moles/volume] in Serum or Plasma
2068
17313
1.86
29.83
20.2
12.1
mmol/l
139.5
139.5
0.46
2016
16742
(3023103) Potassium [Moles/volume] in Serum or Plasma
2071
17347
1.86
29.81
20.2
12.2
mmol/l
3.9
3.9
0.48
2012
16714
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
318
1570
2.09
29.53
7.1
7.4
mmol/l
23.7
23.9
0.55
304
1484
(3018418) pH of Serum or Plasma
648
4083
1.71
27.92
4.4
3.9
ph
7.4
7.4
0.41
90
753
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
25
17
14.29
26.78
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
689
4459
1.67
26.65
3.7
2.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1190
8799
1.57
26.51
8.7
7.1
%
0.6
0.6
0.06
1137
8332
(42870588) Differential panel, method unspecified - Blood
937
6557
1.60
26.41
8.4
7.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
279
1366
2.09
26.37
8.9
9.1
mmol/l
0.8
0.7
0.11
205
1058
(3014111) Lactate [Moles/volume] in Serum or Plasma
282
1395
2.07
25.91
7.5
9.7
mmol/l
1.3
1.4
1.15
266
1309
(3030467) Casts [#/volume] in Urine by Automated count
715
4702
1.65
25.85
4.8
3.2
e6/l
0.4
0.3
0.13
537
3468
(3012095) Magnesium [Moles/volume] in Serum or Plasma
407
2287
1.85
25.73
8.7
6.2
mmol/l
0.8
0.8
0.20
384
2140
(3001604) Monocytes [#/volume] in Blood
1264
9520
1.56
25.65
8.7
6.9
e9/l
0.6
0.6
2.78
1084
8231
(3020779) Urea [Moles/volume] in Serum or Plasma
301
1531
2.01
25.61
12.4
10.3
mmol/l
6.9
7.2
0.32
288
1474
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1935
16111
1.69
25.56
5.0
4.1
mu/l
2.8
1.9
0.54
1820
14995
(3006315) Basophils [#/volume] in Blood
1266
9544
1.56
25.54
8.7
6.9
e9/l
0.0
0.0
0.39
1083
8258
(3013115) Eosinophils [#/volume] in Blood
1300
9866
1.56
25.40
9.4
7.3
e9/l
0.2
0.2
0.11
1131
8678
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
322
1684
1.96
25.30
2.1
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
276
1372
2.05
25.00
9.0
9.1
kpa
5.1
5.1
0.31
254
1307
(3027801) Oxygen [Partial pressure] in Arterial blood
276
1372
2.05
25.00
9.0
9.1
kpa
13.0
13.5
0.66
253
1309
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
845
5835
1.59
24.82
5.1
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
756
5094
1.61
24.54
4.9
3.3
e6/l
148.1
70.6
0.32
575
3833
(3006504) Eosinophils/100 leukocytes in Blood
1209
9084
1.54
24.30
8.7
6.9
%
2.9
2.9
0.16
1158
8577
(40758558) Short blood count panel - Blood
722
4822
1.62
24.25
9.7
7.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1699
13774
1.58
24.18
4.2
3.5
pmol/l
14.6
14.7
0.94
1569
12419
(3019069) Monocytes/100 leukocytes in Blood
1215
9148
1.54
24.13
9.0
7.1
%
8.5
8.3
1.19
1164
8680
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
131
477
2.73
24.13
2.6
2.8
ug/l
207.8
428.1
1.19
116
440
(3023183) Ammonium ion [Moles/volume] in Plasma
112
376
2.95
23.97
3.1
3.1
umol/l
31.4
33.7
0.53
101
324
(3036489) Thrombin time
186
805
2.32
23.81
4.6
4.9
s
22.0
22.1
0.04
168
736
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
950
6790
1.56
23.77
3.3
2.5
nmol/l
69.2
71.0
1.22
879
6273
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
318
1693
1.93
23.63
2.2
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
591
3784
1.66
23.36
4.6
4.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
485
2954
1.72
23.10
1.6
1.4
nmol/l
18.7
20.1
1.37
440
2580
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
413
2403
1.78
23.09
2.2
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
122
439
2.76
22.99
7.2
5.9
%
1.7
1.7
0.02
111
405
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1023
7506
1.53
22.31
7.6
6.0
umol/l
14.3
13.3
0.51
957
6991
(36304419) Bacteria [Presence] in Urine
700
4719
1.59
22.28
4.8
3.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
129
487
2.63
22.14
1.7
2.4
mmol/l
3.6
3.6
0.29
120
455
(3019198) Lymphocytes [#/volume] in Blood
1295
9997
1.51
22.13
8.6
6.8
e9/l
2.1
2.1
0.23
1135
8861
(3013650) Neutrophils [#/volume] in Blood by Automated count
1380
10806
1.51
21.94
13.4
9.1
e9/l
4.0
3.9
0.89
1186
9361
(3044290) Cell count panel - Cerebral spinal fluid
124
461
2.67
21.94
2.0
2.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
120
439
2.71
21.91
7.3
5.8
%
0.9
0.9
0.38
110
404
(3019309) Folate [Moles/volume] in Red Blood Cells
371
2137
1.79
21.35
1.8
1.7
nmol/l
975.7
1177.7
5.05
294
1602
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
161
692
2.32
20.93
12.0
12.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
306
1672
1.87
20.89
7.8
8.3
mmol/l
105.0
104.5
0.83
296
1638
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
198
929
2.14
20.80
5.3
3.8
ng/l
194.4
204.3
0.14
188
816
(3022948) Iron [Moles/volume] in Serum or Plasma
405
2411
1.74
20.75
3.1
2.5
umol/l
12.1
14.0
5.68
378
2247
(3018010) Neutrophils/100 leukocytes in Blood
1230
9501
1.48
20.23
8.6
6.6
%
54.3
54.0
0.47
1179
9028
(3002030) Lymphocytes/100 leukocytes in Blood
1244
9648
1.48
19.94
8.7
6.8
%
31.0
31.5
0.65
1194
9144
(3026782) Osmolality of Urine
517
3321
1.63
19.76
3.8
2.8
mosm/kgh2o
557.3
569.1
0.52
455
2842
(3009343) pH of Capillary blood
306
1716
1.82
19.15
11.2
7.0
ph
7.4
7.4
0.55
18
120
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
627
4246
1.56
19.08
2.6
2.5
mg/l
2.9
2.8
0.52
550
3691
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
302
1689
1.82
19.06
11.2
7.0
mmol/l
1.0
1.1
0.17
222
1207
(3004789) Transferrin [Mass/volume] in Serum or Plasma
371
2210
1.72
18.84
3.1
2.5
g/l
2.4
2.5
0.08
340
2062
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
306
1725
1.81
18.81
11.1
7.0
kpa
5.1
5.0
0.46
292
1639
(3018095) Leukocytes [#/volume] in Urine
852
6190
1.49
18.57
5.6
3.8
e6/l
48.8
87.6
1.56
601
4131
(3022313) Gas panel - Capillary blood
261
1407
1.88
18.51
11.8
7.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
51
122
4.09
18.40
3.0
2.6
umol/l
62.8
51.8
1.51
42
108
(3016018) Differential panel - Cerebral spinal fluid
79
253
3.07
18.40
1.9
2.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
235
1229
1.93
18.27
9.9
9.7
%
95.6
95.9
0.19
217
1180
(3002385) Erythrocyte distribution width [Ratio]
1965
16860
1.57
18.23
22.4
13.6
%
13.5
13.3
4.03
1931
16519
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
53
133
3.90
17.93
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
345
2043
1.73
17.84
3.3
2.6
%
19.6
23.4
6.33
300
1807
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2164
19048
1.69
17.57
11.6
8.4
u/l
28.1
27.6
0.45
2096
18405
(3023410) Appearance of Cerebral spinal fluid
81
274
2.91
17.16
2.2
3.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
120
497
2.39
16.98
2.0
2.5
e6/l
24.0
13.7
0.46
92
372
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
120
497
2.39
16.98
2.0
2.5
e6/l
1576.2
7928.6
0.38
96
385
(3044640) Blood type and Crossmatch panel - Blood
704
5024
1.49
16.33
2.9
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
98
376
2.57
16.33
9.1
10.0
u/ml
0.4
0.3
0.34
65
202
(3021589) Normoblasts [#/volume] in Blood
1119
8729
1.42
16.09
10.9
9.2
e9/l
0.0
0.0
0.51
876
6980
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
140
3.63
15.95
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
210
1108
1.90
15.86
9.8
9.4
g/l
122.3
123.5
0.34
197
1068
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
506
3397
1.54
15.61
3.1
2.5
mg/l
1.5
1.2
0.80
384
2364
(3031040) Bacteria [#/volume] in Urine by Automated count
1388
11282
1.41
15.61
6.0
4.0
e6/l
1812.6
1664.4
0.04
21
151
(3028707) Methadone [Presence] in Urine by Screen method
193
1000
1.93
15.39
3.3
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1600
13359
1.42
15.28
5.2
4.2
mmol/mol
38.0
37.8
0.38
1512
12530
(3039000) Anion gap in Blood
73
249
2.88
15.26
9.5
7.7
mmol/l
12.0
11.4
0.54
64
219
(3027945) Reticulocytes/100 erythrocytes in Blood
298
1767
1.71
15.23
4.8
4.2
%
1.5
1.6
0.89
268
1622
(3007853) Bacteria identified in Skin by Aerobe culture
346
2135
1.65
15.21
2.0
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
73
250
2.86
15.16
9.5
7.7
mmol/l
105.4
105.1
0.16
64
220
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1469
12110
1.41
14.90
4.5
3.1
u/l
39.7
36.1
1.30
1411
11508
(3011397) Hemoglobin [Presence] in Urine by Test strip
579
4039
1.49
14.81
4.2
3.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
228
1262
1.81
14.79
12.6
7.7
kpa
9.6
9.6
0.02
217
1208
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1732
14726
1.43
14.51
4.1
3.2
mmol/l
5.7
5.6
2.05
1598
13519
(3000850) Epithelial cells [#/volume] in Urine
507
3474
1.51
14.06
4.0
2.7
e6/l
7.5
6.5
0.72
454
3050
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
102
430
2.34
13.91
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
102
430
2.34
13.91
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
60
194
3.03
13.81
7.8
8.1
mg/l
10.4
9.8
0.32
52
178
(3047181) Lactate [Moles/volume] in Blood
93
378
2.42
13.76
8.3
6.2
mmol/l
1.5
1.2
0.61
83
326
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
51
150
3.32
13.72
10.9
9.9
mmol/l
0.6
0.6
0.66
46
139
(3052851) Hemolysis interference index of Serum or Plasma
113
504
2.21
13.50
2.9
3.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
449
3024
1.52
13.46
2.3
1.7
%
1.5
1.4
4.95
402
2751
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
45
124
3.54
13.38
1.7
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
142
697
2.02
13.24
11.1
12.5
mmol/l
24.2
24.1
0.09
135
658
(3008152) Bicarbonate [Moles/volume] in Arterial blood
141
691
2.02
13.20
7.1
6.8
mmol/l
24.4
24.3
0.09
123
639
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
67
239
2.74
12.94
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
289
1776
1.64
12.82
2.9
2.2
nmol/l
322.1
370.8
4.43
265
1639
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
157
810
1.92
12.69
7.1
6.5
%
91.4
93.0
0.37
152
773
(3044889) 12 lead EKG panel
1191
9635
1.36
12.64
3.5
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
628
4573
1.43
12.55
3.1
2.6
u/l
54.7
55.3
0.09
583
4216
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
65
233
2.73
12.45
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
506
3554
1.46
12.23
1.7
1.7
mmol/l
1.4
1.3
0.48
458
3129
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
57
194
2.87
12.03
1.9
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
201
1139
1.76
12.03
8.1
5.5
ng/l
72.0
71.8
0.01
187
1051
(4198724)
69
262
2.58
11.82
3.0
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
248
1504
1.65
11.57
2.4
2.3
u/l
27.1
65.2
0.62
221
1252
(3019060) Gas panel - Arterial blood
138
705
1.94
11.50
6.0
5.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
299
1903
1.58
11.44
5.5
4.3
umol/l
8.5
7.3
0.48
249
1603
(3051593) INR in Capillary blood by Coagulation assay
20
32
6.06
11.42
8.6
18.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
635
4701
1.40
11.39
4.1
3.7
mmol/l
8.4
8.5
0.29
562
4102
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
544
3924
1.43
11.30
2.8
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
166
907
1.82
11.23
1.5
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
208
1218
1.70
11.07
4.3
3.5
e9/l
64.5
68.2
0.92
158
854
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2110
18898
1.47
11.01
17.7
11.0
mg/l
23.7
22.6
0.74
1660
13943
(3003338) MCHC [Mass/volume]
2009
17840
1.42
10.88
23.1
13.5
g/l
333.9
334.8
3.79
1995
17667
(3007461) Platelets [#/volume] in Blood
2369
21812
1.85
10.86
25.5
15.6
e9/l
258.2
257.1
0.34
2294
21113
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
416
2874
1.47
10.83
4.6
3.7
ng/l
1361.4
1286.3
0.14
360
2342
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
156
846
1.83
10.82
1.9
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
951
7557
1.34
10.80
4.4
4.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
142
751
1.87
10.67
6.0
5.7
g/l
3.2
3.1
0.12
134
729
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
61
230
2.59
10.63
1.0
1.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
160
881
1.80
10.57
2.2
2.8
g/l
65.8
66.4
0.39
146
809
(3024731) MCV [Entitic volume]
2369
21841
1.82
10.38
25.4
15.5
fl
88.3
88.6
2.96
2347
21528
(3035941) MCH [Entitic mass]
2369
21842
1.82
10.36
25.4
15.5
pg
29.6
29.7
4.53
2347
21530
(3026361) Erythrocytes [#/volume] in Blood
2369
21846
1.82
10.29
25.5
15.6
e12/l
4.6
4.6
1.09
2282
21094
(3000963) Hemoglobin [Mass/volume] in Blood
2369
21854
1.81
10.16
25.8
15.7
g/l
135.9
137.4
4.63
2346
21533
(3010813) Leukocytes [#/volume] in Blood
2369
21863
1.80
10.01
25.6
15.6
e9/l
6.9
6.8
1.60
2285
21119
(3035637) Corticotropin [Mass/volume] in Plasma
76
330
2.25
9.77
1.9
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1417
12019
1.31
9.74
5.9
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
611
4602
1.37
9.63
4.8
3.1
ng/l
44.6
93.0
0.54
389
2516
(3042936) Bacteria identified in Isolate by Culture
320
2149
1.50
9.53
2.3
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
326
2207
1.48
9.33
3.2
2.7
mmol/l
2.4
2.4
0.22
269
1913
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1774
15573
1.33
9.26
4.3
3.5
mmol/l
2.6
2.7
5.57
1671
14530
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
87
409
2.08
9.19
2.5
1.9
ug/l
3.0
2.6
0.11
69
351
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1061
8699
1.30
9.19
3.4
2.8
ug/l
83.3
90.0
0.61
1009
8162
(40761511) CBC panel - Blood by Automated count
2160
19604
1.44
8.82
15.7
9.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
27
71
3.69
8.67
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
128
705
1.79
8.49
5.0
5.2
g/l
0.2
0.3
2.49
83
420
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
185
1127
1.63
8.48
1.8
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
32
96
3.24
8.45
2.0
2.5
umol/l
120.4
147.8
0.27
18
53
(3013707) Erythrocyte sedimentation rate by Westergren method
1438
12350
1.28
8.36
4.7
3.8
mm/h
9.9
8.9
2.64
1353
11425
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
25
64
3.79
8.34
1.7
2.0
umol/l
16.8
14.9
0.38
25
64
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
43
4.50
8.34
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
78
366
2.08
8.31
2.4
9.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
16
29
5.34
8.06
9.2
10.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1675
14713
1.29
7.92
3.7
3.0
mmol/l
1.3
1.2
3.90
1571
13773
(3049233) Organic acids panel - Urine
15
26
5.58
7.91
1.0
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
53
217
2.38
7.86
1.2
1.2
mg/l
52.0
37.7
0.75
48
170
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
55
230
2.33
7.78
1.8
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
38
133
2.78
7.73
3.7
2.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
117
646
1.78
7.72
4.4
3.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
48
190
2.46
7.66
1.6
1.3
promille
0.9
1.4
1.36
38
148
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
232
1526
1.51
7.62
3.9
3.3
g/l
0.2
0.2
0.06
216
1442
(3041354) Potassium [Moles/volume] in Venous blood
39
140
2.71
7.57
3.6
2.7
mmol/l
4.1
4.0
0.67
39
140
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
143
844
1.67
7.44
18.3
12.9
mg/l
1.2
1.2
0.28
137
805
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1747
15484
1.28
7.37
4.1
3.3
mmol/l
4.4
4.5
13.15
1665
14579
(3009542) Hematocrit [Volume Fraction] of Blood
2092
19018
1.36
7.24
21.1
12.1
%
40.0
40.6
3.30
1695
15684
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1731
15340
1.28
7.22
4.0
3.2
mmol/l
1.3
1.4
17.12
1634
14367
(3035285) Chloride [Moles/volume] in Venous blood
38
139
2.66
7.13
3.7
2.8
mmol/l
105.1
105.5
0.26
38
139
(3022217) INR in Platelet poor plasma by Coagulation assay
198
1280
1.53
7.06
23.2
20.6
inr
1.5
1.2
1.13
20
192
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
47
192
2.38
7.04
1.8
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
135
798
1.66
7.00
11.6
11.7
%
0.6
0.7
1.09
130
791
(3019150) Specific gravity of Urine by Refractometry
517
3969
1.32
6.90
4.5
3.4
kg/l
1.0
1.0
1.30
75
596
(36660697) Celiac disease serology panel - Serum
309
2190
1.41
6.87
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
16
6.64
6.81
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
201
2.32
6.81
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
31
105
2.86
6.73
1.9
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
719
5797
1.27
6.55
1.4
1.5
u/ml
3.1
2.4
0.26
152
1348
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
133
802
1.63
6.41
11.7
11.6
%
1.3
1.3
0.35
127
794
(3013336) Amino acids [Identifier] in Serum or Plasma
19
49
3.75
6.31
1.5
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1684
14989
1.25
6.14
13.9
9.3
ml/min/173m2
97.7
96.6
0.94
1303
11535
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
351
2589
1.35
6.11
1.6
1.6
pmol/l
37333759.1
13049819.3
0.28
300
2207
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
227
1555
1.45
6.10
4.2
5.0
u/l
247.5
258.9
0.47
217
1477
(3051611) Lipemic interference index of Serum or Plasma
45
193
2.27
6.08
2.7
4.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
12
22
5.27
5.97
1.1
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
32
120
2.59
5.78
1.0
1.1
u/l
1.3
1.0
0.95
13
58
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
100
580
1.69
5.63
1.7
2.0
g/l
1.8
1.3
3.05
87
512
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
312
1.94
5.56
1.9
2.1
g/l
3.2
3.2
0.01
49
244
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
20
5.31
5.51
1.4
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
62
314
1.92
5.47
1.8
2.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
41
3.77
5.38
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1008
8579
1.22
5.37
4.5
3.3
estimate
0.0
0.0
0.80
146
1662
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
55
269
1.99
5.36
2.0
2.1
g/l
37.4
38.1
0.35
47
232
(3021387) Prolactin [Units/volume] in Serum or Plasma
178
1195
1.47
5.33
1.7
1.6
mu/l
414.2
310.8
2.46
160
1077
(3007164) IgA [Mass/volume] in Serum or Plasma
639
5190
1.25
5.29
1.6
1.5
g/l
2.0
2.0
0.00
338
3072
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
332
1.88
5.26
1.9
2.0
g/l
3.8
3.8
0.02
48
238
(4027681)
42
187
2.18
5.24
1.2
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
333
1.87
5.22
1.9
2.0
g/l
7.4
7.4
0.07
48
249
(44790049)
58
292
1.93
5.22
2.4
1.9
—
—
—
0
0
(44790048)
58
292
1.93
5.22
2.4
1.9
—
—
—
0
0
(44790047)
58
292
1.93
5.22
2.4
1.9
—
—
—
0
0
(44806118)
58
292
1.93
5.22
2.4
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
307
1.90
5.15
1.9
2.1
g/l
10.4
10.1
0.22
48
264
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50
240
2.03
5.15
2.1
2.2
g/l
0.0
0.0
0.00
44
222
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
80
450
1.73
5.07
1.5
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
53
262
1.97
5.04
2.0
2.2
g/l
0.0
0.0
0.17
47
244
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
80
452
1.73
4.99
2.4
2.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
51
250
1.98
4.97
3.3
2.2
mmol/l
72.4
73.0
0.03
41
212
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
333
1.84
4.91
1.9
2.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
49
238
2.00
4.90
2.1
2.3
g/l
0.0
0.0
0.00
44
222
(3045414) Leukocytes [Presence] in Urine
105
641
1.60
4.89
2.0
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1001
8581
1.20
4.79
6.5
4.6
estimate
0.0
0.0
0.50
161
1717
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
19
5.08
4.78
1.1
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
86
2.70
4.77
7.9
8.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
23
4.62
4.75
1.4
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
8
7
11.03
4.67
1.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
290
1.88
4.67
2.0
2.3
g/l
0.8
0.6
0.14
49
257
(3000060) B lymphocytes [#/volume] in Blood
41
190
2.09
4.66
3.5
3.1
e6/l
387.6
312.3
0.37
29
114
(3005719) IgG [Mass/volume] in Serum or Plasma
224
1613
1.37
4.55
3.7
2.8
g/l
9.8
10.0
0.47
213
1485
(3009214) Lutropin [Units/volume] in Serum or Plasma
160
1091
1.44
4.46
1.9
1.8
u/l
6.3
6.8
0.36
109
824
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
49
247
1.93
4.44
2.9
2.9
e6/l
617.3
561.0
0.25
40
185
(21494755) Public health laboratory ask at order entry panel
188
2436
0.72
4.42
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1003
8646
1.19
4.42
4.6
3.3
estimate
0.0
0.0
0.50
153
1671
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
145
973
1.46
4.40
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
60
325
1.80
4.36
2.2
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
78
456
1.67
4.34
2.4
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
56
298
1.83
4.32
2.3
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
403
3172
1.27
4.32
4.0
4.3
mg/mmol
10.6
11.5
0.12
285
2173
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
230
1.94
4.28
3.3
2.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
103
2.44
4.27
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
388
3045
1.27
4.26
3.4
2.9
umol/l
5590.2
5866.5
0.04
344
2716
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
24
92
2.53
4.22
1.3
1.1
nmol/l
4.9
0.8
—
10
13
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
48
245
1.90
4.21
2.9
2.9
e9/l
0.2
0.2
0.00
40
186
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
401
1.70
4.21
11.6
6.5
u/ml
2202.3
385.2
0.45
11
30
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
134
894
1.47
4.20
2.4
2.3
ug/l
5.6
7.0
0.45
114
769
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
81
2.63
4.18
4.5
5.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
47
239
1.91
4.17
3.2
2.8
%
10.0
10.6
0.19
42
188
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
98
615
1.56
4.11
2.4
2.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
47
242
1.89
4.03
3.2
2.8
%
71.1
70.2
0.12
47
236
(3017509) Phencyclidine [Presence] in Urine
15
46
3.15
3.92
2.8
2.6
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
46
3.15
3.92
10.7
7.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
254
1910
1.31
3.89
2.8
2.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
34
159
2.07
3.83
2.7
4.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
382
3031
1.25
3.81
3.5
3.5
mg/l
870.4
212.6
1.17
284
2095
(3014051) Protein [Presence] in Urine by Test strip
62
355
1.70
3.77
2.3
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
146
1013
1.41
3.74
3.1
3.2
pmol/l
4.8
4.8
0.15
130
904
(3011412) CD3 cells [#/volume] in Blood
51
277
1.79
3.73
3.1
2.8
e9/l
1.5
1.4
0.19
39
164
(3024891) Influenza virus A+B Ag [Presence] in Specimen
112
740
1.48
3.72
1.3
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
15
372
0.38
3.61
1.5
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
51
280
1.77
3.61
6.8
4.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
82
2.48
3.59
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
291
2252
1.28
3.58
2.8
2.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
8
12
6.43
3.57
1.0
1.6
nmol/l
27.9
21.0
—
8
12
(3034860) Kappa light chains.free [Mass/volume] in Serum
45
241
1.81
3.46
2.0
3.4
mg/l
36.1
75.8
0.83
36
191
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
108
2.24
3.44
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
517
5746
0.83
3.44
2.4
2.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
45
242
1.80
3.42
2.0
3.4
mg/l
32.8
33.5
0.03
36
192
(3001019) Free T4 and TSH panel - Serum or Plasma
64
968
0.63
3.41
1.2
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
95
619
1.50
3.41
1.8
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
231
1749
1.30
3.38
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
51
286
1.73
3.37
5.4
4.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
22
91
2.34
3.34
1.8
1.2
%
58.6
92.7
—
5
10
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
142
2.05
3.31
2.8
2.1
mg/l
44.9
27.5
—
7
42
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
60
354
1.65
3.30
1.8
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
46
2.94
3.29
2.3
2.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
46
2.94
3.29
2.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
218
1645
1.30
3.28
3.6
2.9
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
10
6.75
3.27
1.6
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
10
6.75
3.27
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
395
4482
0.82
3.25
1.8
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
261
1.75
3.23
2.3
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
60
357
1.63
3.21
4.7
4.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
242
1858
1.28
3.19
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
140
994
1.38
3.18
1.2
1.2
—
—
—
0
0
(4306422)
48
270
1.72
3.16
1.1
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
37
3.13
3.13
2.0
2.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
70
2.49
3.12
1.3
1.3
nmol/l
194.9
136.7
1.50
18
70
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
76
2.42
3.11
1.3
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
76
2.42
3.11
1.7
1.9
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
76
2.42
3.11
1.3
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
143
1023
1.37
3.11
2.0
1.7
iu/l
9.0
11.6
0.78
101
777
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
103
698
1.44
3.06
1.3
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
22
95
2.24
3.06
3.8
3.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
57
343
1.61
2.94
1.2
1.2
u/ml
26.7
24.9
—
6
23
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
359
4072
0.82
2.93
1.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
299
1.65
2.91
1.5
1.3
u/ml
6.1
5.0
0.14
30
141
(3017446) Testosterone [Moles/volume] in Serum or Plasma
212
1622
1.28
2.89
2.3
2.1
nmol/l
11.8
12.8
0.72
186
1432
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
150
1095
1.34
2.88
2.4
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
53
315
1.63
2.88
2.8
2.6
%
17.9
17.3
0.61
27
162
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
51
301
1.64
2.85
1.1
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
21
92
2.21
2.84
1.1
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
15
56
2.59
2.83
7.1
6.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
62
2.49
2.81
1.3
1.6
mmol/l
11.3
9.8
0.32
11
50
(4010399)
134
967
1.35
2.78
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
303
2430
1.23
2.76
2.7
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
319
1.61
2.75
2.0
2.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
39
216
1.75
2.75
1.7
1.7
mosm/kgh2o
287.9
287.6
0.02
27
159
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
15
57
2.54
2.74
8.0
6.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
75
2.32
2.73
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
303
2433
1.23
2.73
2.8
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
75
490
1.49
2.72
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
74
483
1.49
2.70
7.5
4.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
74
484
1.49
2.67
10.1
7.4
iu/ml
698.8
357.1
0.36
12
62
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
23
3.78
2.67
1.3
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
41
2.83
2.66
2.2
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
76
2.29
2.66
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
136
993
1.34
2.63
2.9
2.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
20
89
2.17
2.62
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
297
2392
1.22
2.60
2.8
2.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
77
2.26
2.59
1.3
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
19
4.06
2.58
1.3
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
299
2413
1.22
2.57
2.8
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
57
356
1.55
2.56
2.2
2.5
g/l
132.7
134.5
0.20
46
283
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
27
137
1.91
2.52
2.5
1.9
nmol/l
0.2
0.1
0.44
20
100
(3023511) Choriogonadotropin [Units/volume] in Urine
118
850
1.35
2.51
1.7
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
148
1103
1.31
2.50
4.9
3.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
166
1257
1.29
2.49
2.0
1.8
g/l
1.0
1.1
0.93
154
1165
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
44
260
1.64
2.48
1.4
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
37
209
1.71
2.47
2.7
2.7
e6/l
741.8
815.0
—
6
54
(40757494) Bilirubin.total [Moles/volume] in Blood
21
98
2.07
2.46
4.2
3.9
umol/l
72.5
119.4
—
6
34
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
48
293
1.59
2.39
1.6
1.3
u/ml
7.0
5.0
0.21
23
103
(3015171) Extractable nuclear Ab [Units/volume] in Serum
86
593
1.41
2.39
1.3
1.2
u/ml
0.4
1.1
—
6
38
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
65
903
0.68
2.39
1.5
1.5
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
7
16
4.22
2.39
1.1
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
87
1147
0.72
2.37
1.8
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
192
1491
1.26
2.36
1.4
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
33
2.92
2.36
1.5
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
69
461
1.45
2.29
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
180
2136
0.80
2.28
1.6
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
34
2.84
2.25
1.0
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
64
423
1.47
2.25
1.4
1.4
ug/g
293.7
319.6
0.58
38
215
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
33
186
1.72
2.24
1.3
1.4
pmol/l
298.9
332.1
0.22
25
143
(3037756) Immunofixation for Serum or Plasma
31
172
1.74
2.22
1.2
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
197
1547
1.24
2.22
1.4
1.3
u/ml
507.7
319.1
0.46
178
1434
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
249
2845
0.82
2.20
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
74
988
0.71
2.20
1.8
1.8
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
13
4.45
2.19
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
117
1.90
2.17
1.7
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
37
218
1.64
2.15
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
194
1527
1.24
2.15
1.4
1.2
iu/ml
108.8
151.8
0.92
55
549
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
112
1398
0.76
2.14
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
53
2.37
2.10
3.6
2.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
154
1.76
2.08
1.8
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
18
85
2.05
2.08
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
78
1020
0.73
2.06
1.6
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
54
353
1.48
2.03
6.1
4.3
mmol/l
1.7
2.1
0.78
36
215
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
42
2.53
2.02
1.6
1.7
—
—
—
0
0
(4035726)
140
1070
1.27
2.01
1.5
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
135
1.79
1.98
1.1
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
15
3.86
1.96
1.0
1.3
%
43.3
21.9
—
6
9
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
40
247
1.57
1.95
6.6
4.7
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
15
68
2.13
1.93
8.5
5.4
mmol/l
1.2
1.2
0.01
15
62
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
264
1.54
1.91
1.8
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
181
1.66
1.89
1.9
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
38
234
1.57
1.89
1.4
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
39
242
1.56
1.88
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
149
1160
1.25
1.85
2.4
2.3
au/ml
8.9
17.6
—
5
71
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
36
220
1.58
1.85
1.8
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
198
1.61
1.83
1.2
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
40
252
1.54
1.81
1.0
1.0
mu/l
9.3
9.1
0.09
33
208
(3020961) Endomysium IgA Ab [Titer] in Serum
182
1454
1.22
1.79
1.2
1.2
titre
265.0
308.9
—
6
51
(3045424) Erythrocytes [Presence] in Urine
36
222
1.57
1.79
1.3
1.5
—
—
—
0
0
(4268621)
35
215
1.57
1.77
2.7
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
377
3212
1.15
1.76
2.8
3.0
ug/g
134.3
133.1
0.02
304
2586
(4024509)
19
98
1.87
1.76
1.7
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
33
201
1.59
1.73
9.3
7.3
mmol/l
7.3
6.6
0.36
28
161
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
205
1664
1.20
1.72
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
52
2.23
1.72
1.8
1.3
ug/l
11.0
9.2
0.69
12
52
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
40
256
1.51
1.70
1.1
1.1
iu/ml
6.8
7.6
—
9
46
(44816559) Phosphatidylethanol [Mass/volume] in Blood
77
557
1.34
1.69
1.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
142
1114
1.24
1.67
2.3
2.2
e9/l
4.2
4.1
0.15
116
937
(3006270) Folate [Moles/volume] in Blood
20
107
1.81
1.67
1.2
1.1
nmol/l
323.9
383.4
0.63
14
98
(3019225) pH of Specimen
147
1159
1.23
1.66
6.2
3.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
13
3.71
1.65
1.4
1.3
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
13
3.71
1.65
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
61
427
1.38
1.64
1.2
1.2
u/ml
28.5
46.5
—
6
21
(3025941) Bacteria identified in Stool by Culture
148
1170
1.23
1.63
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
462
4910
0.88
1.62
4.5
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
186
1509
1.20
1.59
6.9
5.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
567
5947
0.89
1.59
2.8
2.5
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
5
14
3.44
1.55
1.0
1.0
g/l
150.2
166.1
—
5
14
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
14
3.44
1.55
1.2
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
65
465
1.35
1.55
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
286
1.45
1.55
1.8
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
42
2.30
1.54
5.1
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
42
2.30
1.54
5.1
2.4
—
—
—
0
0
(3010421) pH of Blood
59
416
1.37
1.54
5.9
4.0
ph
7.4
7.4
0.29
53
349
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
89
669
1.29
1.52
2.5
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
85
635
1.30
1.52
2.6
1.8
u/ml
77.7
97.3
—
6
86
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
169
1366
1.20
1.51
3.6
2.9
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
20
2.89
1.51
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
72
527
1.32
1.49
2.0
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
43
2.24
1.47
3.7
3.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
235
1.48
1.44
1.4
1.3
g/l
2.4
2.5
0.20
31
184
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
235
1.48
1.44
1.4
1.3
g/l
0.4
0.4
0.56
31
181
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.01
1.38
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
39
2.23
1.38
1.1
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
77
577
1.29
1.37
1.9
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
102
792
1.25
1.36
1.3
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
92
706
1.26
1.36
1.1
1.1
u/ml
1.1
8.0
—
5
108
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
160
1.57
1.36
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
12
58
2.00
1.36
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
200
1661
1.17
1.34
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
23
138
1.61
1.33
1.8
2.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
57
411
1.34
1.33
4.3
3.7
mmol/l
1.7
1.5
0.55
52
404
(3011648) Oxygen content in Venous blood
29
185
1.51
1.31
2.9
14.3
%
11.8
11.6
0.12
29
185
(3014765) Yersinia sp identified in Stool by Organism specific culture
79
599
1.28
1.30
1.3
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
148
1202
1.20
1.30
4.7
4.1
%
0.4
0.4
0.01
27
272
(3035933) Granulocytes/100 leukocytes in Blood
10
185
0.52
1.27
1.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
530
5515
0.90
1.27
2.6
2.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
110
1.67
1.26
1.2
1.1
ratio
1.0
1.1
—
6
46
(3037522) Nuclear Ab [Titer] in Serum
279
2388
1.14
1.26
1.5
1.4
titre
459.5
494.9
0.16
43
414
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
78
594
1.27
1.25
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
160
1314
1.18
1.25
5.0
4.4
%
1.0
0.7
0.29
40
367
(40768800) Prostate Pathology biopsy report
5
115
0.42
1.24
1.0
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
8
35
2.20
1.23
1.4
1.3
—
—
—
0
0
(4062490)
35
236
1.43
1.22
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
141
1597
0.84
1.22
5.7
3.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
54
393
1.33
1.21
1.2
1.2
u/ml
1.5
4.6
—
5
42
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
173
1.51
1.21
3.6
3.4
nmol/l
0.7
0.8
0.54
20
135
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
197
1.47
1.20
1.4
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
36
2.14
1.20
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
42
547
0.73
1.19
1.2
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
20
120
1.61
1.18
2.8
2.3
mmol/l
1.9
2.1
0.14
12
94
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
50
362
1.34
1.17
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
128
1.58
1.16
4.7
2.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
128
1.58
1.16
4.4
4.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
124
0.46
1.16
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
79
609
1.26
1.16
1.3
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
54
396
1.32
1.16
1.2
1.2
u/ml
1.7
15.2
—
5
59
(3045788) Cell count panel - Pleural fluid
16
91
1.70
1.14
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
30
200
1.45
1.13
1.4
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
99
1.66
1.12
1.0
1.5
e6/l
67366.0
97767.4
—
10
58
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
175
1932
0.86
1.12
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
78
927
0.80
1.12
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
56
1.89
1.10
4.6
6.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
39
1.98
1.10
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
93
737
1.22
1.08
1.3
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
20
123
1.57
1.08
1.6
2.4
%
36.4
43.0
—
8
38
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
448
0.73
1.06
1.8
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
17
101
1.62
1.05
1.1
1.1
iu/ml
298.9
212.2
0.46
17
101
(40760888) Immunoglobulin light chains.free panel - Serum
27
179
1.46
1.05
1.6
3.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
32
2.11
1.04
1.6
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
21
132
1.54
1.04
2.5
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
38
272
1.35
0.98
1.3
1.4
u/l
8.4
12.3
1.01
30
243
(3018738) Hemoglobin F/Hemoglobin.total in Blood
15
88
1.64
0.98
3.8
4.1
%
4.6
2.5
—
5
34
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
182
1.43
0.98
1.4
1.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
14
216
0.62
0.98
2.9
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
14
216
0.62
0.98
5.9
5.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
150
1255
1.16
0.98
5.1
4.5
%
0.1
0.1
0.47
38
343
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
28
0.00
0.98
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
28
0.00
0.98
0.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
81
1.67
0.96
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
199
1.41
0.96
1.4
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
31
0.00
0.95
0.0
1.1
—
10.0
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
9
49
1.77
0.94
1.4
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
67
1.73
0.93
3.5
4.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
60
1.77
0.92
1.1
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
6
27
2.14
0.91
1.3
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
280
0.68
0.91
1.6
1.5
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
24
161
1.44
0.91
1.5
1.6
u/ml
32.7
6.8
—
5
41
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
194
1.39
0.89
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
83
1.63
0.89
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
266
2811
0.90
0.89
2.4
2.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
40
1.93
0.89
1.1
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
29
1.99
0.86
1.3
4.6
—
—
—
0
0
(3013512) EKG study
379
3382
1.09
0.85
5.3
3.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
196
1.38
0.85
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
116
1.50
0.83
2.8
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
198
1.37
0.81
1.4
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
31
1.86
0.81
1.2
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
109
1.50
0.81
1.9
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
95
781
1.18
0.81
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
182
1.38
0.80
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
122
1024
1.15
0.80
5.4
4.0
mmol/l
1.2
1.2
0.42
115
880
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
199
1.36
0.79
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
142
1206
1.14
0.79
5.3
4.6
%
0.0
0.4
0.56
31
300
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
23
0.00
0.79
0.0
1.6
—
7.2
—
0
13
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
105
1166
0.86
0.78
1.6
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
25
0.00
0.78
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
32
1.81
0.78
1.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
27
0.00
0.76
0.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
288
2554
1.10
0.76
3.6
4.1
ug/l
3.1
2.5
0.29
254
2276
(3012441) Differential panel - Pleural fluid
16
103
1.50
0.75
1.0
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
111
1.48
0.75
4.4
2.8
u/ml
1175.1
923.5
0.35
17
111
(3043409) Potassium [Moles/volume] in Arterial blood
44
337
1.26
0.75
2.9
3.8
mmol/l
3.8
3.9
0.70
36
309
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
77
627
1.19
0.74
1.6
2.0
u/l
33.7
39.8
2.45
68
581
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
78
636
1.19
0.74
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
103
1139
0.86
0.74
1.4
1.3
miu/ml
247.4
240.2
0.06
38
540
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
19
128
1.43
0.73
1.4
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
37
1.82
0.73
4.7
6.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
37
1.82
0.73
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
24
2.01
0.72
1.2
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
24
2.01
0.72
1.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
245
1.30
0.72
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
9
54
1.61
0.72
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
399
3600
1.08
0.71
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
699
7026
0.94
0.70
2.4
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
186
0.67
0.69
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
66
1.61
0.69
1.3
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
21
146
1.39
0.69
1.4
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
13
82
1.53
0.68
1.2
1.2
u/l
404.0
460.4
0.10
13
73
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
180
1.34
0.67
1.3
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
96
1056
0.87
0.66
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
30
223
1.30
0.66
1.7
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
40
309
1.25
0.66
1.5
1.3
—
—
—
0
0
(44806071)
5
27
1.78
0.66
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
147
1571
0.89
0.65
1.9
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
99
1.46
0.65
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
91
1.48
0.65
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
43
1.57
0.64
2.6
1.3
—
—
—
0
0
(4034850)
55
442
1.20
0.64
11.1
7.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
52
416
1.21
0.63
2.5
2.3
nmol/l
1.0
0.6
0.89
43
354
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
174
1.33
0.63
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
116
1.41
0.63
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
116
1.41
0.63
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
116
1.41
0.63
1.5
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
55
443
1.20
0.62
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
108
1.43
0.62
1.3
1.4
e6/l
287604.5
170765.2
0.20
11
79
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
114
974
1.13
0.62
1.2
1.2
u/ml
3.1
2.1
0.32
70
551
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
97
1060
0.88
0.62
1.5
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
29
217
1.29
0.62
1.1
1.2
u/ml
73.8
17.9
0.38
20
175
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
97
1059
0.88
0.61
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
97
1059
0.88
0.61
1.5
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
61
1.58
0.60
2.1
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
50
1.54
0.59
1.8
2.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
51
1.51
0.58
2.3
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
51
1.51
0.58
2.3
2.2
—
—
—
0
0
(1002224) Polysomnography panel
76
635
1.16
0.58
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
160
1.33
0.58
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
160
1.33
0.58
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
160
1.33
0.58
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
519
1.17
0.57
1.4
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
102
1.42
0.57
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
99
844
1.13
0.57
2.1
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
395
1.20
0.57
4.5
3.9
%
54.5
54.3
0.03
49
395
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
332
3392
0.93
0.56
2.6
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
35
1.65
0.56
3.0
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
161
1.32
0.56
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
161
1.32
0.56
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
53
1.45
0.56
4.9
6.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
36
1.61
0.55
2.8
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
63
702
0.86
0.54
1.7
1.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
128
1.36
0.54
1.2
1.2
u/l
103.7
144.2
—
10
89
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
49
397
1.19
0.54
1.6
1.6
nmol/l
0.2
0.4
1.60
44
325
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
121
0.64
0.54
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
162
1.31
0.54
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
96
821
1.13
0.54
2.2
1.6
u/ml
207.3
192.7
0.22
52
457
(3024980) IgG subclass 4 [Mass/volume] in Serum
46
371
1.20
0.54
1.3
1.7
g/l
0.7
0.8
0.19
40
302
(3042517) Benzodiazepines panel - Urine
9
59
1.47
0.53
7.0
2.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
20
251
0.76
0.53
1.5
1.5
mmol/l
6.5
6.7
0.12
15
170
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
381
1.19
0.52
4.2
1.9
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
38
1.52
0.52
1.2
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
95
0.61
0.52
1.3
1.2
—
41.5
—
0
6
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
121
1.35
0.52
1.1
1.0
miu/ml
1844.9
1418.5
0.70
17
121
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
96
0.60
0.52
1.3
1.2
—
76.1
—
0
11
(3038026) Centromere Ab [Units/volume] in Serum
6
97
0.59
0.51
1.3
1.2
—
56.4
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
39
1.48
0.51
1.7
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
44
1.53
0.48
1.4
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
171
0.73
0.48
1.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
99
857
1.12
0.47
4.1
4.1
ug/l
5.5
25.0
1.17
76
672
(3000475) Leukocytes [#/volume] in Synovial fluid
36
288
1.21
0.47
1.6
1.7
e6/l
17205.6
16217.1
0.05
26
204
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
201
1.25
0.46
1.5
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
107
1.35
0.46
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
47
1.43
0.46
1.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
74
1.43
0.45
1.9
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
67
568
1.14
0.45
1.1
1.1
u/ml
8.4
9.7
0.21
35
312
(3021879) Hepatitis B virus core Ab [Presence] in Serum
248
2245
1.07
0.45
1.7
1.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
48
1.40
0.45
6.3
6.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
335
1.18
0.44
3.1
2.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
179
0.75
0.44
1.6
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
15
108
1.34
0.44
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
124
0.70
0.43
1.6
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
125
0.69
0.43
1.3
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
53
584
0.87
0.43
1.4
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
5
30
1.61
0.43
1.0
1.1
—
0.7
—
0
16
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
67
1.44
0.42
4.2
7.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
89
0.65
0.42
1.3
1.2
—
37.6
—
0
8
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
111
975
1.10
0.42
2.9
2.6
ml/min/173m2
77.1
75.9
0.10
36
364
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.55
0.42
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
177
0.76
0.41
1.6
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.2
—
1.7
—
0
15
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
18
135
1.29
0.41
1.7
1.7
mmol/l
6.7
6.0
0.51
11
108
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
16
0.00
0.41
0.0
1.2
—
66.6
—
0
16
(3025549) Creatine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
25
196
1.23
0.41
1.3
1.3
u/ml
67.0
11.5
0.71
16
156
(3030905) Polymorphonuclear cells [#/volume] in Blood
46
383
1.16
0.41
3.3
3.6
e9/l
3.9
3.8
0.04
46
383
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
46
384
1.16
0.40
1.2
1.1
iu/ml
37.6
186.1
—
10
134
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
18
0.00
0.39
0.0
1.1
—
26.5
—
0
12
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
95
832
1.10
0.39
1.8
1.6
mg/l
5.3
3.7
0.49
72
548
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
216
1959
1.07
0.39
3.9
3.8
%
25.9
21.6
2.32
76
774
(3044242) Glucose [Moles/volume] in Arterial blood
9
64
1.35
0.38
2.1
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
111
1.30
0.38
2.8
4.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
65
1.33
0.37
2.1
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
67
1.29
0.37
2.1
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
68
1.27
0.36
1.8
1.5
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
10
130
0.74
0.36
1.1
1.0
—
11.0
—
0
13
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
183
0.79
0.35
1.7
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
298
1.17
0.35
1.3
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
151
0.76
0.35
1.7
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
77
0.62
0.35
1.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
26
209
1.20
0.35
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
26
209
1.20
0.35
1.0
1.0
kpa
7.1
7.3
0.11
21
170
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
87
1.33
0.34
1.2
1.1
%
78.2
88.2
—
5
43
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
174
1778
0.94
0.34
2.0
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
50
541
0.89
0.33
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
88
1.31
0.32
1.2
1.0
%
90.2
92.5
—
5
44
(44813793)
25
202
1.19
0.32
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
45
1.28
0.32
1.3
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
45
1.28
0.32
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
87
911
0.92
0.32
2.1
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
50
539
0.89
0.32
1.2
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
45
383
1.13
0.32
4.3
3.4
u/ml
1287.2
3606.0
0.41
38
327
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
283
0.85
0.31
1.2
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
7
51
1.32
0.31
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
34
285
1.15
0.30
2.4
2.6
ug/min
183.8
132.4
0.18
28
184
(3022145) Colonoscopy Study observation
171
1558
1.06
0.29
1.4
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
54
1.25
0.29
1.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
27
223
1.17
0.29
1.2
1.3
—
149.2
—
0
13
(3029075) Extractable nuclear Ab panel - Serum
12
90
1.28
0.29
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
97
868
1.08
0.28
1.2
1.2
u/ml
2.6
3.5
0.33
34
274
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
187
0.82
0.28
1.3
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
25
206
1.17
0.27
1.0
1.0
kpa
3.7
3.3
0.27
20
168
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
62
1.24
0.27
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
62
1.24
0.27
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
189
1.17
0.26
1.3
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
72
0.67
0.26
1.2
1.2
u/l
19.4
10.8
—
5
63
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
71
739
0.92
0.25
1.5
1.6
iu/ml
21.9
7.5
0.27
16
163
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
363
1.12
0.25
2.4
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1797
17430
0.97
0.25
3.7
3.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
48
419
1.10
0.24
1.1
1.1
u/ml
3.0
3.9
0.20
16
187
(40765089) Chromosome analysis panel - Blood by G-banded
25
209
1.15
0.24
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
273
1.13
0.24
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
189
1743
1.05
0.23
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
135
1367
0.95
0.23
1.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
120
1.20
0.22
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
69
617
1.08
0.22
1.1
1.1
u/ml
5.3
6.4
0.18
37
318
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
161
1481
1.05
0.22
4.5
3.3
%
32.3
31.9
0.21
127
1031
(40765096) Chromosome analysis panel by Banding
5
40
1.20
0.21
1.6
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
10.8
—
0
5
(3009015) Lactate [Moles/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.1
—
7.1
—
0
6
(3022475) Manganese [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
49
433
1.09
0.21
1.9
1.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
13
0.00
0.20
0.0
7.8
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
13
0.00
0.20
0.0
1.6
—
2.2
—
0
6
(3014891) Appearance of Pleural fluid
0
13
0.00
0.20
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
46
1.26
0.20
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
47
1.23
0.20
1.2
3.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
14
113
1.19
0.20
1.8
1.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
50
1.16
0.19
1.2
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
51
1.13
0.18
1.5
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
51
1.13
0.18
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
187
1.13
0.18
3.0
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
137
0.84
0.18
4.8
3.1
%
51.0
53.7
—
6
89
(3024263) Appearance of Synovial fluid
7
58
1.16
0.17
1.6
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
133
1.16
0.17
1.4
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
151
1399
1.04
0.17
2.5
2.6
ug/l
0.7
0.7
0.36
97
810
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
65
0.74
0.17
1.4
3.2
u/ml
16.3
45.1
—
5
65
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
267
2501
1.03
0.17
1.2
1.2
iu/ml
20.1
26.1
0.70
52
672
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
427
0.92
0.17
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
38
397
0.92
0.16
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
19
161
1.14
0.16
1.1
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
68
1.13
0.16
2.6
2.3
u/l
199.3
201.9
—
8
68
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
69
1.12
0.16
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
75
1.16
0.15
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
75
1.16
0.15
1.4
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
75
1.16
0.15
1.4
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
61
554
1.06
0.15
1.6
1.5
titre
48.9
64.3
—
9
53
(40768793) Breast Pathology biopsy report
23
245
0.90
0.14
1.4
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
134
0.86
0.14
1.3
1.2
%
87.8
81.2
0.20
12
134
(3029396) Erythrocyte agglutination [Presence] in Blood
8
92
0.84
0.13
2.3
3.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
133
0.87
0.13
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
453
4291
1.02
0.13
5.9
4.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
153
0.88
0.13
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
103
0.84
0.13
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
35
362
0.93
0.13
3.6
3.0
mg/l
25.1
26.7
0.09
24
224
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
28
248
1.09
0.12
2.3
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
272
0.92
0.12
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
82
1.17
0.12
1.3
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
427
1.06
0.12
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
261
0.92
0.11
1.7
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
59
595
0.95
0.11
2.0
2.3
u/ml
23.5
47.5
1.82
53
564
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
174
1636
1.03
0.10
2.9
2.6
u/l
13301.7
7042.7
0.72
47
611
(3030313) Adrenal Ab [Titer] in Serum
5
42
1.15
0.10
2.6
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
5
42
1.15
0.10
9.0
3.1
—
126.1
—
0
13
(3020874) Milk IgE Ab [Units/volume] in Serum
35
317
1.06
0.10
1.5
1.3
u/ml
9.4
3.2
0.40
19
184
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
43
1.12
0.10
1.2
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
43
1.12
0.10
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
44
1.09
0.09
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
44
1.09
0.09
1.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
45
1.07
0.09
2.2
2.1
ug/l
1.9
3.8
—
5
40
(3025577) Chromium [Mass/volume] in Blood
5
46
1.05
0.09
2.4
2.1
ug/l
1.7
2.3
—
5
37
(3047352) Trisomy 18 risk [Likelihood] in Fetus
83
826
0.97
0.09
1.6
1.5
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
52
1.11
0.09
4.5
6.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
149
0.90
0.09
1.9
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
53
1.09
0.09
1.3
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
57
571
0.96
0.08
5.0
3.3
umol/l
10.4
7.6
0.73
42
464
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
55
1.05
0.08
1.3
2.6
—
—
—
0
0
(4038314)
6
56
1.03
0.08
1.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
59
0.82
0.08
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
7
61
1.10
0.08
1.4
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
238
2327
0.98
0.08
1.2
1.2
u/ml
5.5
8.7
0.55
65
849
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
699
6675
1.01
0.08
1.9
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
83
823
0.97
0.08
1.5
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
19
169
1.08
0.08
1.4
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
576
5496
1.01
0.07
1.9
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
52
520
0.96
0.07
1.1
1.1
u/ml
0.1
0.4
2.72
21
183
(3006462) Nitrate [Presence] in Urine
8
72
1.07
0.07
1.5
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
95
1.11
0.06
1.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
91
0.85
0.06
1.1
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
29
265
1.05
0.06
1.2
1.1
u/ml
1.2
2.3
—
10
66
(3029937) Albumin [Presence] in Urine by Test strip
479
4572
1.01
0.06
5.2
3.5
estimate
0.0
0.0
1.34
154
1662
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
105
1.10
0.06
1.6
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
136
0.92
0.05
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
136
0.92
0.05
9.5
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
136
0.92
0.05
9.5
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
543
5262
0.99
0.05
1.9
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
10
106
0.91
0.05
1.8
2.6
u/field
0.6
2.3
—
5
56
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
46
429
1.03
0.05
1.9
1.9
iu/l
4.1
4.5
0.11
20
163
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
680
6574
0.99
0.04
5.0
3.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
126
1.07
0.03
4.5
3.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
93
909
0.98
0.03
1.1
1.2
u/ml
5.1
7.6
0.81
61
611
(3008401) Mugwort IgE Ab [Units/volume] in Serum
93
882
1.02
0.03
1.1
1.2
u/ml
1.5
1.1
0.14
55
531
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
21
210
0.96
0.02
1.2
1.5
mmol/l
10.0
11.7
—
9
38
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
142
0.95
0.02
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
142
0.95
0.02
2.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
99
1.07
0.02
2.5
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
99
1.07
0.02
1.2
1.1
—
—
—
0
0
(4094501)
25
233
1.03
0.02
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
109
1.06
0.01
1.6
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
416
1.02
0.01
1.2
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10
90
1.07
0.01
3.2
5.7
u/ml
—
883.4
—
0
21
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
119
1.05
0.01
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
22
218
0.97
0.01
1.5
2.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
295
0.98
0.01
1.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
639
6143
1.00
0.00
1.6
1.7
—
—
—
0
0
(4146454)
10
93
1.03
0.00
3.3
2.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
16
159
0.97
0.00
1.7
1.2
—
4.4
—
0
7
(3021788) Differential panel - Synovial fluid
24
233
0.99
0.00
1.3
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
63
611
0.99
0.00
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
195
0.99
0.00
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
163
1.00
0.00
1.4
1.2
nmol/l
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
234
0.99
0.00
4.2
3.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
140
0.96
0.00
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
87
838
1.00
0.00
1.6
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
33
315
1.01
0.00
1.8
1.3
u/ml
12.3
9.4
0.18
18
172
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
126
0.99
0.00
1.5
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
96
0.90
0.00
1.7
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
68
0.99
0.00
1.9
1.8
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
68
0.99
0.00
1.9
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
68
0.99
0.00
1.9
1.8
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
68
0.99
0.00
1.9
1.8
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
56
0.86
0.00
1.2
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
8
79
0.97
0.00
1.5
2.7
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
8
81
0.95
0.00
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
49
0.98
0.00
2.0
2.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
6
64
0.90
0.00
1.2
1.3
—
50.1
—
0
13
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(40758292) HTLV I+II Ab panel - Serum
5
51
0.94
0.00
1.2
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
49
0.98
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
77
1.00
0.00
1.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
518.4
—
0
7
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
49
0.98
0.00
2.0
2.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
9.0
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
53
0.91
0.00
2.0
1.9
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
94
0.92
0.00
1.2
1.2
—
1.4
—
0
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
57
1.01
0.00
1.2
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
7.0
—
6.8
—
0
5
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
32.9
—
0
7
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
83
0.93
0.00
1.6
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
38.3
—
0
9
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
74
0.91
0.00
1.1
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_SPEECH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SPEECH | 2.33 [1.63, 3.33] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.521 |
During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 16064 females with F5_SPEECH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SPEECH | 1.96 [1.3, 2.95] | 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 439 out of 36866 males with F5_SPEECH died.
Mortality risk
Mortality risk for people of age
years, who have F5_SPEECH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.163% | 0.335% |
| 5 | 1.268% | 2.075% |
| 10 | 3.551% | 5.315% |
| 15 | 6.847% | 10.057% |
| 20 | 12.053% | 16.402% |
Relationships between endpoints
↥Index endpoint: F5_SPEECH – Specific development disorders of speech and language
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data